[video] Jim Cramer Quick Take: How to Play CVS Kicking the Tobacco Habit
NEW YORK (TheStreet) -- CVS Caremark
"I applaud the decision of CVS to drop tobacco," said TheStreet's Jim Cramer, co-manager of the Action Alerts PLUS portfolio manager. However, he's in the business of caring more about earnings per share. So Cramer is concerned many of CVS' customers will head over to Rite-Aid
Rite-Aid has had some very good quarters and has been aggressively pushing its private-label products, Cramer said. Another beneficiary could be Walgreen
Cramer also suggested that investors look at Dollar General
CVS said the decision may initially cost the company $2 billion in annual revenue, leaving Cramer to conclude that investors may want to shift to these other companies.